Furthermore, the pattern of IL-17+, IFNγ+ and IL-4+ CD4+T-lymphocytes production detected in new-onset DMARD-naïve RA patients could be modified by MTX treatment, and two different behaviors were identified in responders and nonresponders. Here, IL4 is linked to rheumatoid arthritis.